IDO1 and depressive symptom measurement: As IDO activation was proposed to mediate a change in serotoninergic neurotransmission during the development of depression, the hypothesis was raised that nanoZnO may provide some positive benefit to the cognitive impairment or other injuries accompanied by the depressive-like behaviors.